FdaApplication
NDA 022314
Identifiers
- fda_app_no: NDA022314
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2009-04-30 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 10MG BASE;25MG;160MG | TABLET;ORAL |
| EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 10MG BASE;12.5MG;160MG | TABLET;ORAL |
| EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 5MG BASE;12.5MG;160MG | TABLET;ORAL |
| EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 5MG BASE;25MG;160MG | TABLET;ORAL |
| EXFORGE HCT | AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN | EQ 10MG BASE;25MG;320MG | TABLET;ORAL |
5 products